US Bancorp’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$113K Sell
3,148
-685
-18% -$24.7K ﹤0.01% 2363
2025
Q1
$151K Buy
3,833
+15
+0.4% +$591 ﹤0.01% 2170
2024
Q4
$115K Sell
3,818
-986
-21% -$29.7K ﹤0.01% 2325
2024
Q3
$112K Sell
4,804
-24
-0.5% -$561 ﹤0.01% 2338
2024
Q2
$85.9K Sell
4,828
-1,402
-23% -$24.9K ﹤0.01% 2409
2024
Q1
$94.8K Buy
6,230
+1,143
+22% +$17.4K ﹤0.01% 2392
2023
Q4
$86.9K Buy
5,087
+4,650
+1,064% +$79.4K ﹤0.01% 2406
2023
Q3
$3.65K Sell
437
-9,276
-96% -$77.5K ﹤0.01% 3509
2023
Q2
$241K Buy
9,713
+7,363
+313% +$183K ﹤0.01% 1756
2023
Q1
$35.3K Sell
2,350
-20,348
-90% -$306K ﹤0.01% 2685
2022
Q4
$269K Buy
22,698
+19,432
+595% +$230K ﹤0.01% 1706
2022
Q3
$19K Buy
3,266
+1,978
+154% +$11.5K ﹤0.01% 3038
2022
Q2
$5K Sell
1,288
-170
-12% -$660 ﹤0.01% 3585
2022
Q1
$14K Buy
1,458
+1,074
+280% +$10.3K ﹤0.01% 3247
2021
Q4
$7K Sell
384
-38
-9% -$693 ﹤0.01% 3529
2021
Q3
$14K Sell
422
-13,130
-97% -$436K ﹤0.01% 3287
2021
Q2
$525K Buy
13,552
+88
+0.7% +$3.41K ﹤0.01% 1532
2021
Q1
$649K Buy
13,464
+703
+6% +$33.9K ﹤0.01% 1368
2020
Q4
$664K Buy
+12,761
New +$664K ﹤0.01% 1290
2016
Q2
Sell
-5,020
Closed -$43K 3634
2016
Q1
$43K Hold
5,020
﹤0.01% 2452
2015
Q4
$60K Hold
5,020
﹤0.01% 2354
2015
Q3
$51K Sell
5,020
-60
-1% -$610 ﹤0.01% 2448
2015
Q2
$84K Sell
5,080
-4,430
-47% -$73.3K ﹤0.01% 2260
2015
Q1
$147K Sell
9,510
-115
-1% -$1.78K ﹤0.01% 1924
2014
Q4
$152K Sell
9,625
-1,150
-11% -$18.2K ﹤0.01% 1897
2014
Q3
$115K Hold
10,775
﹤0.01% 2032
2014
Q2
$101K Buy
+10,775
New +$101K ﹤0.01% 2121